Oculis Holding AG (OCS) Cash from Operations (2022 - 2026)

Oculis Holding AG (OCS) recorded quarterly Cash from Operations of 19585420.81 in Q1 2026, up 6.16% quarter-over-quarter from 20870763.3 in Q4 2025, and up 7.14% on a YoY basis from 18280015.07 in Q1 2025.

Oculis Holding AG (OCS) Cash from Operations (2022 - 2026) Analysis & Trends

Oculis Holding AG's Cash from Operations history runs 5 years deep, the most recent figure standing at 19585420.81 for Q1 2026.

  • In Q1 2026, Cash from Operations rose 7.14% year-over-year to 19585420.81; the TTM figure through Mar 2026 stood at 78056596.89 (down 28.13% YoY), while the FY2025 annual figure was 82957561.87, down 48.56% from the prior year.
  • Cash from Operations was 19585420.81 for Q1 2026 at Oculis Holding AG, up from 20870763.3 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 6781397.15 in Q4 2022 to a low of 21091606.91 in Q1 2025.
  • Historically, Cash from Operations has averaged 15322007.63 across 5 years, with a median of 15718761.35 in 2024.
  • The sharpest annual moves came in 2023 and 2024: Cash from Operations sank 136.21% in 2023, then advanced 24.15% in 2024.
  • A 5-year view of Cash from Operations shows it stood at 6781397.15 in 2022, then tumbled by 136.21% to 16018579.72 in 2023, then advanced by 24.15% to 12150358.55 in 2024, then slumped by 71.77% to 20870763.3 in 2025, then increased by 6.16% to 19585420.81 in 2026.
  • The last three Cash from Operations figures came in at 19585420.81 (Q1 2026), 20870763.3 (Q4 2025), and 16773969.47 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -1.67 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -12.20 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -2.49 Mn
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 1.43 Bn
9 Abivax 90.15 Bn 90.15 Bn - -
10 Oculis Holding AG 8.23 Bn 7.92 Bn - -19.59 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -19.59 Mn
Mar 31, 2026 -19.59 Mn
Dec 31, 2025 -20.87 Mn
Dec 31, 2025 -20.87 Mn
Sep 30, 2025 -16.77 Mn
Sep 30, 2025 -16.77 Mn
Jun 30, 2025 -20.83 Mn
Jun 30, 2025 -20.83 Mn
Mar 31, 2025 -21.09 Mn
Mar 31, 2025 -21.09 Mn
Dec 31, 2024 -12.15 Mn
Dec 31, 2024 -12.15 Mn
Sep 30, 2024 -12.48 Mn
Sep 30, 2024 -12.48 Mn
Jun 30, 2024 -15.19 Mn
Jun 30, 2024 -15.19 Mn
Mar 31, 2024 -15.72 Mn
Mar 31, 2024 -15.72 Mn
Dec 31, 2023 -16.02 Mn
Dec 31, 2023 -16.02 Mn